Author:
Bonafede Machaon,McMorrow Donna,Noxon Virginia,Desai Pooja,Sapra Sandhya,Silberstein Stephen
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference22 articles.
1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;24[Suppl 1]:9–160.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646–57.
3. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–62.
4. American Migraine Foundation. Preventive treatments. 2016. https://americanmigrainefoundation.org/understanding-migraine/preventive-treatments/. Accessed 4 Feb 2020.
5. Institute for Clinical and Economic Review (ICER). Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value. California Technology Assessment Forum: Institute for Clinical and Economic Review; 2018.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献